These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 27594295)
1. Design, docking analysis, identification, and synthesis of novel 3-(((substituted phenyl) amino)methyl)-2-methylquinazolin-4(3H)-one compounds to fight tuberculosis. Panneerselvam T; Sivakumar A; Arumugam S; Joshi SD Drug Discov Ther; 2016; 10(4):188-94. PubMed ID: 27594295 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles. Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents. Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents. Balaji NV; Hari Babu B; Subbaraju GV; Purna Nagasree K; Murali Krishna Kumar M Bioorg Med Chem Lett; 2017 Jan; 27(1):11-15. PubMed ID: 27894872 [TBL] [Abstract][Full Text] [Related]
5. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain. Raja S; Prakash CR Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents. Kamal A; Reddy BV; Sridevi B; Ravikumar A; Venkateswarlu A; Sravanthi G; Sridevi JP; Yogeeswari P; Sriram D Bioorg Med Chem Lett; 2015 Sep; 25(18):3867-72. PubMed ID: 26253635 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase. Lu W; Baig IA; Sun HJ; Cui CJ; Guo R; Jung IP; Wang D; Dong M; Yoon MY; Wang JG Eur J Med Chem; 2015 Apr; 94():298-305. PubMed ID: 25771108 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and molecular docking study of novel triazole-quinazolinone hybrids as antimalarial and antitubercular agents. Mhetre UV; Haval NB; Bondle GM; Rathod SS; Choudhari PB; Kumari J; Sriram D; Haval KP Bioorg Med Chem Lett; 2024 Aug; 108():129800. PubMed ID: 38763480 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis. Liu P; Yang Y; Ju Y; Tang Y; Sang Z; Chen L; Yang T; An Q; Zhang T; Luo Y Bioorg Chem; 2018 Oct; 80():422-432. PubMed ID: 30005200 [TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents. Desai NC; Trivedi AR; Somani HC; Bhatt KA Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines. Nayyar A; Monga V; Malde A; Coutinho E; Jain R Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis. Venugopala KN; Dharma Rao GB; Bhandary S; Pillay M; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K Drug Des Devel Ther; 2016; 10():2681-90. PubMed ID: 27601885 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives. Candéa AL; Ferreira Mde L; Pais KC; Cardoso LN; Kaiser CR; Henriques Md; Lourenço MC; Bezerra FA; de Souza MV Bioorg Med Chem Lett; 2009 Nov; 19(22):6272-4. PubMed ID: 19819134 [TBL] [Abstract][Full Text] [Related]
16. 2(3H)-furanones and 2(3H)-pyrrolones: synthesis and antimycobacterial evaluation. Husain A; Alam MM; Hasan SM; Yar MS Acta Pol Pharm; 2009; 66(2):173-80. PubMed ID: 19719052 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel carbazole tethered pyrrole derivatives as potent inhibitors of Mycobacterium tuberculosis. Surineni G; Yogeeswari P; Sriram D; Kantevari S Bioorg Med Chem Lett; 2015 Feb; 25(3):485-91. PubMed ID: 25559743 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and antitubercular evaluation of novel 2-substituted-3H-benzofuro benzofurans via palladium-copper catalysed Sonagashira coupling reaction. Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S Bioorg Med Chem Lett; 2013 Oct; 23(19):5393-6. PubMed ID: 23953191 [TBL] [Abstract][Full Text] [Related]
20. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents. Ramprasad J; Nayak N; Dalimba U Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]